Back to all bills
S 3134119th CongressIn Committee
Combating Counterfeit Pharmaceuticals Act of 2025
Introduced: Nov 6, 2025
Sponsor: Sen. Cotton, Tom [R-AR] (R-Arkansas)
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Combating Counterfeit Pharmaceuticals Act expands the Fentanyl Sanctions Act to address trafficking of counterfeit drugs and copy-cat pharmaceutical ingredients.
Key Points
- 1Adds definitions for copy-cat ingredients and counterfeit drugs
- 2Expands sanctions to cover all illicit drugs beyond opioids
- 3Authorizes intelligence community to target foreign drug traffickers
- 4Includes waiver for access to prescription medications during shortages
- 5Delegates authorities to designees of the Director of National Intelligence
- 6Updates reporting requirements to cover broader illicit drug trafficking
Impact Areas
International drug trafficking enforcementPharmaceutical safetyIntelligence community operationsForeign sanctions policyMedication supply chain security
Generated by kwaipilot/kat-coder-pro:free on Nov 19, 2025